Déesse PRO is preparing to launch the strongest professional-grade mask to hit the market yet –EOS-X.
Designed in the UK and precision-engineered in Korea, EOS-X is the first medical-grade LED solution to feature 1070nm wavelength technology. Clinically proven to penetrate deeper into the subcutaneous tissue and muscle, the near-infrared wavelength prompts a bio-stimulatory effect on ageing and compromised tissue, whilst also improving microcirculation and cellular oxygenation.
The combined application of three wavelengths in the anti-ageing medical mode of EOS-X is designed to elicit synergistic immune responses within the body that are completely painless. The 1070nm wavelength initiates a pro-inflammatory response akin to that of a laser or chemical peel, simulating a 'wound' effect deep in the muscle. Subsequently, the 630nm and 830nm wavelengths stimulate tissue regeneration and healing in the dermis, restoring normal cellular function through an anti-inflammatory response.
EOS-X, named after the Greek goddess of dawn, shines new light on established LED Light Therapy, sometimes called Photobiostimulation or Low-Level Laser Therapy (LLLT), the new model integrates FDA-approved medical efficacy with holistic well-being, supporting patient demand for treatments that balance skincare outcomes with overall wellness and vitality.
Distributed and wholly owned by Harpar Grace International, EOS-X will launch simultaneously in the UK & USA, ahead of a more comprehensive European roll-out in the summer. It is the brand’s first platform delivery system, a multi-modality device that future Déesse PRO wavelength and wellbeing products will be integrated with.
CEO Alana Chalmers comments:
“Our new technology equips the practitioner with the capability to unlock the most extensive range of wavelengths in the market for aesthetic and wellbeing applications. Coupled with our at-home devices, the Déesse PRO portfolio unlocks unrivalled integration and treatment journeys that are commercially progressive and a must for the future needs of our practitioners and their patients”.
EOS-X Model Highlights
In trials of Red and NIR lights, at the four-week point, fine lines and wrinkles were clinically reduced by over a third (38%) among subjects. At the 8-week marker, 91% of subjects reported improved skin tone, 82% reported improved smoothness, 64% reported improved clarity, and 55% reported improved firmness.
Blue light remains a clinically proven, non-invasive acne treatment that is suitable for all Fitzpatrick scale skin tones and skin types. After 12 weeks, subjects reported an 81% reduction in superficial and deeper acne lesions, including comedones, papules, and nodules.
RRP: GBP 2,495
EOS-X by Déesse PRO is exclusively available for clinics, medispas, and private medical practices on dessepro.com.